Tumlin James, Stacul Fulvio, Adam Andy, Becker Christoph R, Davidson Charles, Lameire Norbert, McCullough Peter A
Southeast Renal Research Institute (SERRI), Charlotte, North Carolina 28028, USA.
Am J Cardiol. 2006 Sep 18;98(6A):14K-20K. doi: 10.1016/j.amjcard.2006.01.020. Epub 2006 Feb 17.
Contrast-induced nephropathy (CIN) is the third leading cause of acute kidney injury in hospitalized patients and is associated with significant patient morbidity. The pathogenesis of CIN is complex and not fully understood, but iodinated contrast agents induce intense and prolonged vasoconstriction at the corticomedullary junction of the kidney. Moreover, high-osmolar dyes directly impair the autoregulatory capacity of the kidney through a loss of nitric oxide production. These effects, coupled with direct tubular toxicity of contrast media, lead to overt acute tubular necrosis and the syndrome of CIN.
对比剂肾病(CIN)是住院患者急性肾损伤的第三大主要原因,且与患者的显著发病率相关。CIN的发病机制复杂且尚未完全明确,但含碘对比剂会在肾脏的皮质髓质交界处引起强烈且持久的血管收缩。此外,高渗性染料通过一氧化氮生成减少直接损害肾脏的自身调节能力。这些效应,再加上对比剂直接的肾小管毒性,导致明显的急性肾小管坏死和CIN综合征。